Form D Friday: Dallas biotech firm raises $44M to fight ovarian cancer


Dallas cancer drug maker Gradalis, which is run by the former president of the Mary Crowley Cancer Research Centers, has raised nearly $44 million.

Previous Clearwater cybersecurity company is a funding standout in Florida
Next Regions: Here's why we're selling insurance unit to BB&T